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Pharmaceutical and biomedical applicationsTHEDES, so called therapeutic deep eutectic solvents are here defined as a mixture of two components,
which at a particular molar composition become liquid at room temperature and in which one of them
is an active pharmaceutical ingredient (API). In this work, THEDES based on menthol complexed with
three different APIs, ibuprofen (ibu), BA (BA) and phenylacetic acid (PA), were prepared. The interactions
between the components that constitute the THEDES were studied by NMR, confirming that the eutectic
system is formed by H-bonds between menthol and the API. The mobility of the THEDES components was
studied by PFGSE NMR spectroscopy. It was determined that the self-diffusion of the species followed the
same behavior as observed previously for ionic liquids, in which the components migrate via jumping
between voids in the suprastructure created by punctual thermal fluctuations. The solubility and perme-
ability of the systems in an isotonic solution was evaluated and a comparison with the pure APIs was
established through diffusion and permeability studies carried out in a Franz cell. The solubility of the
APIs when in the THEDES system can be improved up to 12 fold, namely for the system containing
ibu. Furthermore, for this system the permeability was calculated to be 14  105 cm/s representing a
3 fold increase in comparison with the pure API. With the exception of the systems containing PA an
increase in the solubility, coupled with an increase in permeability was observed. In this work, we hence
demonstrate the efficiency of THEDES as a new formulation for the enhancement of the bioavailability of
APIs by changing the physical state of the molecules from a solid dosage to a liquid system.
 2017 Elsevier B.V. All rights reserved.1. Introduction
Pharmaceutical sciences face major challenges associated with
drug solubility and permeability, which result in an inadequate
pharmacokinetics and poor bioavailability of the active pharma-
ceutical ingredient (API) [1]. According to the biopharmaceutics
classification system (BCS) the drugs can be categorized in four
main groups based on their solubility and permeability [2] (Fig. 1):
This classification system is often related to the solubility in
simulated body fluids and gastrointestinal permeability. Nonethe-
less, in vitro models have been adopted to determine the perme-
ability of the drugs in synthetic membranes mimicking the effect
of a tissue. To overcome the problem of low solubility and/or low
permeability of drugs, often higher dosages are administered lead-ing to potential systemic toxicity and severe side effects. Pharma-
ceutical innovations require either crystal engineering strategies
coupled with new methods of administration and novel delivery
systems able to provide a more effective and patient compliant
therapy.
Crystal engineering has been the focus of different studies
which aim is to promote the enhancement of solubility and/or per-
meability of APIs [3]. Various methods, namely the creation of
metastable polymorphs, amorphization, salt formation or co-
crystal formation have been proposed in order to manipulate the
APIs properties, particularly their crystallinity and consequently
their bioavailability [1,4]. On the other hand, the manipulation of
the physical and/or morphological properties of the API itself, for
instance micronization of the powders may also contribute to the
enhancement of drug dissolution and permeability [5]. Other
strategies involve the preparation of more complex systems, such
as suitable delivery systems and the design of new carriers [6–8].
Class I
High solubility
High permeability
Class II
Low solubility
High permeability
Class III
High solubility
Low permeability
Class IV
Low solubility
Low permeability
Solubility
P
er
m
ea
bi
lit
y
Fig. 1. Biopharmaceutics classification system of APIs.
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eutectics as improved pharmaceutical formulations [9]. However,
up to date limited information has been published or reported
for these systems, which are often mistaken for unstable cocrys-
tals. The major difference between eutectics and cocrystals relies
on the interactions and the type of components present in the sys-
tem. An eutectic system is a mixture of two components which
interact trough hydrogen bonding and lead to an overall decrease
in the melting temperature of the system. When the decrease in
the melting temperature is such that the systems become liquid
at room temperature they are so-called deep eutectic solvents
(DES). THEDES – therapeutic deep eutectic solvents have, hence,
been defined as a bioactive eutectic system containing an API as
one of the DES components [10]. Stott and coworkers have
described for the first time a THEDES system composed of menthol
and ibuprofen (Ibu) [11]. The main purpose was the enhancement
of skin permeation and development of transdermal delivery sys-
tems. Similarly, Morrison and coworkers reported a 5–22,000-
fold increase on the solubility of BA (BA), danazol, griseofulvin
and itraconazole in urea-choline chloride and malonic acid-
choline chloride DES [12]. Wang et al. have reported the develop-
ment of an eutectic system of lidocaine:ibu. The results of this
study highlight the differences between the dissolution and per-
meation of the active compounds, which can be finely tuned
towards the development of transdermal delivery systems [13].
The design of new THEDES systems is not easy and lack of
knowledge on the type of interactions and associations established
between the molecules which constitute the THEDES is still hin-
dering the development of new systems. Nonetheless, this
approach is, due to its simplicity, of utmost relevance in the phar-
maceutical field. The preparation of the THEDES systems yields a
100% pure product, with no losses during production and no need
for subsequent purification steps [14]. Furthermore, the scale-up of
the process is relatively straightforward, which is highly important
for the pharmaceutical industry [15].
In a previous work we have reported the development of novel
THEDES based on choline chloride and menthol, combined with
three APIs, namely acetylsalicylic acid, BA and phenylacetic acid
(PA) [16]. It was herein demonstrated that the dissolution rate of
the APIs is greatly enhanced by these systems, particularly in the
case of menthol-based THEDES. The interest in terpenes and partic-
ularly in menthol is mostly due to its effectiveness as permeation
enhancer, which has been reported in the literature [17]. The char-
acterization of the systems in terms of dissolution rate, solubility
and permeability are most relevant to the determination of thesuitable dosage and form of administration. For this reason, in this
work, we have further explored the menthol-based systems: men-
thol:ibu; menthol:BA and menthol:PA and evaluated the solubility
and permeability of the APIs present in the systems. In the partic-
ular case of the systems studied the envisaged route of administra-
tion is the transdermal way. The systems prepared could be
embedded in a patch, providing a more effective delivery of the
API in a local delivery approach.2. Materials and methods
2.1. Materials
The reagents used in the preparation of THEDES were menthol
(99% purity, CAS 89-78-1, Sigma), ibu (>98% purity, CAS 15687-
27-1, Sigma), BA (>99.5% purity, CAS 65-85-0, Sigma) and PA
(99% purity, CAS 103-82-2, Sigma). Fig. 2 presents the chemical for-
mulas of the reagents used. All chemicals were used without any
further purification.
Phosphate buffered saline (PBS) was prepared from phosphate
buffered saline tablets (Sigma), as indicated. One tablet was dis-
solved in 200 mL of deionized water, yielding a 0.01 M phosphate
buffer, 0.0027 M potassium chloride, 0.137 M sodium chloride,
pH 7.4 solution, at 25 C.
2.2. THEDES preparation
THEDES systems prepared were menthol:Ibu (3:1); menthol:BA
(3:1); menthol:PA (2:1) and menthol:PA (3:1). The systems were
prepared by mixing the two components at the given molar ratio
[16]. The mixture was heated to 40 C, under constant stirring,
until a clear liquid solution was formed. Typically the liquid solu-
tion was obtained after a few hours.
2.3. Characterization
2.3.1. NMR studies
All the NMR experiments were carried out in a Bruker Avance
400 spectrometer, equipped with a BBO probe capable of produc-
ing magnetic field gradient pulses up to 53.5 G cm1 in the z-
direction, with a BCUextreme temperature control unit. The
THEDES samples were placed in a 5 mm NMR tube and left for
15 min at the desired temperature (±0.1 C) in order to reach ther-
mal equilibrium. All chemical shifts were referred using tetram-
ethylsilane (TMS) as internal reference and the shim was
performed using a sealed C6D6 capillary tube.
2.3.2. Pulsed-field gradient (PFG) NMR
The diffusion measurements were performed using the stimu-
lated echo sequence using bipolar sine gradient pulses and eddy
current delay before the detection [18]. For each PFGSE experiment
16 spectra of 64 K data points were collected, with a relaxation
delay of 2 s, in which the duration of the magnetic field gradient
(s) was 2–4 ms, the diffusion times was 80 ms (for the diluted sam-
ples) and 800 ms (for the neat samples) and the gradient recovery
was 200 µs. The sine shaped gradient (g) was incremented from 5
to 95% of the maximum gradient strength in a linear ramp (2.68–
50.83 G cm1).
To determine the self-diffusion coefficients, the spectra were
first processed in the F2 dimension by standard Fourier transform
and baseline correction with the Bruker Topspin software package
(version 3.2). The self-diffusion coefficients were calculated by
exponential fitting of the data belonging to individual columns of
the 2D matrix using the Origin 9.0 data software program. In a
PFG NMR experiment the spin echo attenuation decay, I, is related
Fig. 2. Chemical structure of the components used to prepare the therapeutic deep eutectic solvents.
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(Eq. (1)) [19].
I
I0
¼ eq2D Ds3ð Þ ð1Þ
in which D is the self-diffusion coefficient, D is the diffusion time,
and q is the gradient used in the spatial encoding and decoding of
the spin, q = scg, which is a function of the gyromagnetic ratio (c),
the gradient strength (g) and the duration over which the gradient
is applied (s). The gradient coil constant was previously determined
by performing a relative calibration, which implies measuring the
self-diffusion coefficient of a reference substance of known diffu-
sion (deuterated water 99.9%). The diffusion of deuterated water
was measured in a 5 mm NMR tube, at D = 100 ms and
d/2 = 0.8 ms, fixing the self-diffusion coefficient of D2O at
1.95  109 m2 s1 and applying Eq. (1) the gradient coil constant
used in the diffusion coefficients determination was calculated
(53.5 G cm1).2.3.3. Viscosity
The viscosity of the different systems was characterized on a
Kinexus Prot Rheometer (Kinexus Prot, MAL1097376, Malvern) fit-
ted with parallel plate geometry with 20 mm diameter (PU20
SR1740 SS) and 1 mm gap. The steady-state flow measurements
were performed under controlled-stress conditions and a shear
rate of 1 s1 at 20, 25, 30, 35, 40, 45 and 50 C. The data is represent
as the average of ten measurements.2.4. Solubility measurements
The solubility measurements were performed with the pure
APIs and the respective THEDES. Briefly, an excess of API and
THEDES was added to PBS solution at room temperature (20 C)
and stirred for 24 h. The determination of the API solubility was
performed by UV spectroscopy in a microplate reader (BIO-TEK,
SYNERGY HT). The absorbance of the solutions was measured at
the API maximum absorption wavelength, respectively, at
265 nm (ibu), 290 nm (BA) and 230 nm (PA). A calibration curve
using the respective THEDES or the API as standards was prepared
for quantification.2.5. Permeability studies
Permeability measurements were conducted using a glass
Franz-type diffusion cell (PermeGear) with a 8 mL reactor com-
partment with an effective mass transfer area of 1 cm2. The mem-
brane used was a polyethersulphone (PES-U) membrane, with
150 lm thickness and 0.45 lm pore size (Sartorius Stedim Biotech,
Germany), which was placed between the two compartments and
held with a stainless steel clamp. The receptor compartment was
filled with PBS solution, and air bubbles were removed. Afterwards,
the donor compartment was loaded with the same amount of API
in the powder or in the THEDES form and 2 mL of PBS were added.
A concentration of the API in the donor compartment of 2–2.5 mg/
mL was obtained. Aliquots of 200 lL were withdrawn from the
receptor compartment at predetermined time periods (5 min and
hourly from 1 to 8 h) and fresh PBS was added to complete the vol-
ume. The experiments were performed at 37 C, and the receptor
compartment was stirred at 300 rpm using a magnetic bar to elim-
inate the boundary layer effect.
The determination of the API diffused was performed by UV
spectroscopy in a microplate reader (BIO-TEK, SYNERGY HT),
according to what was previously described for the solubility stud-
ies. The cumulative mass of drug diffused to the receptor compart-
ment was determined taking into consideration the replacement of
aliquots with fresh medium and the dilution derived from the
addition of fresh buffer.
The permeability, P of the APIs through the membrane was cal-
culated according to Eq. (2):
 ln 1 2Ct
C0
 
¼ 2A
V
 P  t ð2Þ
where Ct is the concentration in the receptor compartment at time t,
C0 is the initial concentration in the donor compartment, A is the
effective mass transfer area, V is the total volume of solution in both
compartments [20,21].
According to a derived solution of Fick’s law of diffusion it is
possible to determine the diffusion coefficient, D of the API through
the membrane [22]. Eq. (3), was hence applied to the different
systems:
D ¼ V1  V2
V1 þ V2 
h
A
 1
t
ln
Cf  Ci
Cf  Ct
 
ð3Þ
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compartment and Ct is the concentration in the receptor compart-
ment at time t. V1 and V2 are the volume in the donor and in the
receptor compartment respectively and h is the thickness of the
membrane.3. Results and discussion
Solubility and permeability experiments were carried out for
the pure API and for the API when part of a THEDES. To better
understand the solubility and permeability behavior of the API,
the interactions between menthol and the API that form the
THEDES and the self-diffusion coefficients of the individual compo-
nents were studied by NMR spectroscopy.3.1. NMR studies
The menthol:API THEDES were analyzed by NMR spectroscopy.
Fig. 3 shows the 1H NMR spectrum of menthol:PA (3:1) at 298 K,
immediately after formation of the liquid mixture, with the reso-
nances of the two THEDES components referred in the spectrum.
All the THEDES 1H NMR spectra show sharp and well defined
chemical shift signals, with the OH protons of both THEDES com-
ponents corresponding to only one sharp chemical shift (dOH) at
low field (vide supplementary materials). The presence of only
one resonance attributed to both hydroxyl groups of menthol
and carboxylic acid strongly indicates that the both types of pro-
tons are in fast exchange in the NMR timescale. The same interac-
tion was also observed for menthol:BA (3:1) and for menthol:Ibu
(3:1).
The system menthol:PA presented however an unusual behav-
ior, as differences in the spectra were observed with time. A new
set of NMR signals (4.74 ppm, td, 10.7 Hz, 4 Hz; 0.75 ppm, d,
6.8 Hz) was observed 3 h after the formation of the system men-Fig. 3. 1H NMR spectrum of neat menthol:PA (3:1thol:PA (2:1) and 24 h after the formation menthol:PA (3:1) sug-
gesting that these systems were not stable. These signals were
identified as the esterification product between menthol and PA.
The esterification reaction conventionally takes place in the pres-
ence of an activator (acid or base catalyst), or at high temperatures.
For the studied THEDES systems, even at higher temperatures
(323 K), only the menthol:PA showed the ester formation. It was
also observed that after 1 week the reactions where in equilibrium
with a esterification extent of 15 mol% for menthol:PA (2:1) and
6 mol% for menthol:PA (3:1). All further experiments with these
THEDES were only performed after the system was in equilibrium
with no change in its properties. It is important to notice that even
with the presence of a third component the eutectic system was
liquid at room temperature. The dependence on the molar ratio
of menthol to PA strongly suggests that the reaction occurs due
to the fact that PA acts both as reagent and catalyst. The higher
reactivity towards esterification of PA relative to the other APIs
can be explained by the influence of the substituents adjacent to
the carboxylic group that have a retarding effect. In the case of
BA, the phenyl group and the carboxylic group are conjugated,
which lowers the initial energy of the BA relative to PA.
The formation and stability of THEDES liquid structure can be
associated to the formation of hydrogen bonds between its compo-
nents. To further understand the dynamics of the hydrogen bond-
ing in the THEDES we collected 1H NMR spectrum in a temperature
range of 298–323 K. Only the systems with a molar ratio of 3:1
were studied which, in the case of PA, had a higher stability, show-
ing no ester formation during the temperature variation studies.
Temperature variation studies have been one of the most used
approaches to study not only the presence of H-bonds, but also
their nature and strength. The chemical shift dependence on the
temperature for H-bonded protons (both intra and intermolecular)
has been reported in the literature [23,24] and in the case of pro-
teins and peptide it has been used for conformational analysis
[25]. Usually, an increase in temperature was translated into an) at 298 K. All the resonances are attributed.
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decrease of the intermolecular hydrogen bonding (Fig. 4a) and sup-
plementary material). Its magnitude can be quantified by the tem-
perature coefficient (TC). TC was obtained from the slope of the
plot of the chemical shift versus temperature. As depicted in
Fig. 4b), the chemical shift versus temperature shows a linear cor-
relation, with very similar TC values for the studied systems (ca.
19 ppb K1). TC values more negative than 8 ppb K1 are
related to large conformational changes with the temperature
which is associated to intermolecular hydrogen bonding [26]. The
chemical shift of a nucleus is the resonance frequency of the
nucleus relative to a standard at a given temperature, and hence
can be energy related. Therefore the TC gives information about
the strength of the hydrogen bond, i.e. the energy changes of the
H-bond. Analyzing the effect of the carboxylic acid in the (3:1)
THEDES it is observe that the hydrogen bonds are independent
on the API, at all studied temperatures, and apparently of the same
type (intermolecular bonding) and similar energy, which indicates
an analogous global structure.
One of the approaches used towards the understanding of the
macroscopic behavior of the THEDES was by studying the transport
properties of the different components of the THEDES mixture,
which gave an insight to the interactions present in these systems.
PFG NMR allowed the determination of the self-diffusion coeffi-
cients, which are random thermal translational motion of mole-
cules or ions under conditions of thermodynamic equilibrium.
The advantage of PFG-NMR is that it allowed the simultaneously
determination of the self-diffusion coefficients of the different
components of the THEDES, allowing to discriminate between dif-
ferent chemical moieties of the components.
Since all the THEDES studied in this work are menthol based
and have the same menthol:API molar ratio, the differences in
transport properties can be stated to be mostly related to the inter-
actions between the two components.
A typical spin echo attenuation of the PFGSE NMR measure-
ments at different temperatures is shown in Fig. 5.
The logarithm of the spin echo decay of all the THEDES reso-
nances shows a linear correlation with q2 (D  d/3) (Eq. (1)), as
expected for a homogeneous sample. The self-diffusion coefficients
for both components were obtained from the slope of the Stejskal-
Tanner equation (Eq. (1)) in the logarithmic form, i.e., logarithm of I
vs q2 (D  d/3) plot (Table 1).Fig. 4. (a) Representative expansion of the 1H NMR spectra of neat menthol:BA, showing
versus temperature for the studied THEDES.The self-diffusion coefficients of the API are lower than those of
the menthol, independent of the molecular dimension of the API
and the range of temperatures. Carboxylic acids exist in solution
either in the ionic form, with the negative charge delocalized over
the carboxylate group or as dimeric associations. The dimerization
phenomena can explain the lower mobility of the API, in which the
API forms a higher molecular size species, a dimer, which shows a
lower self-diffusion coefficient.
A similar behavior has been reported by D’Agostino et al. [27]
for maline, a NADES formed by choline chloride and malonic acid
(1:1 molecular ratio) in which the authors stated that due to the
dicarboxylic moieties of the malonic acid it would form chains
between the malonic acid molecules, that would create constraints
for the choline chloride motion that would reflect a lower self-
diffusion coefficient for the malonic acid.
The self-diffusion coefficients present, at lower temperatures,
similar values for both THEDES components that, as temperature
increases, start to deviate from each other due to the weakening
of the chemical interaction between the two components.
The self-diffusion dependence on the temperature can be fitted
by a linearization of the Arrhenius equation (Eq. (4)) in order to
determine the activation energy (ED) correspondent to the changes
in the self-diffusion due to the temperature gradient.
lnD ¼ lnD0  EDRT ð4Þ
where T is the temperature (K), D0 is a constant (m2 s1), ED is the
activation energy (kJ mol1) and R is the gas constant
(kJ K1 mol1).
The Arrhenius model shows good agreement with the experi-
mental data, with R2 superior to 0.99. In Table 2, are summarized
the activation energies determined for both components in each
NADES.
Globally the activation energies determined from the self-
diffusion coefficients are in agreement with the viscosity data, with
the higher values of energy – menthol:Ibu (3:1) – corresponding to
the THEDES with higher viscosity. The diffusional activation ener-
gies obtained for the menthol component are higher than the car-
boxylic acid in the menthol:BA (3:1) and menthol:PA (3:1), which
suggests that menthol mobility has a stronger dependence on tem-
perature. This is not the case for the menthol:Ibu (3:1), in which
the diffusional energy of Ibu is higher than menthol, indicating thatthe shift of the OH group as a function of temperature; (b) Plots of d of OH proton
Fig. 5. Logarithm of the spin echo attenuation vs q2 (D  i/3) at different temperatures for the Menthol:BA (3:1): (a) menthol and (b) BA component.
Table 1
Self-diffusion coefficients and viscosity data for the THEDES presented in this study at different temperatures.
Menthol:Ibu (3:1) Menthol:PA (3:1) Menthol:BA (3:1)
T (K) g (mPa s) 1011 DMent
(m2 s1)
1011 DAPI
(m2 s1)
g (mPa s) 1011 DMent
(m2 s1)
1011 DAPI
(m2 s1)
g (mPa s) 1011 DMent
(m2 s1)
1011 DAPI
(m2 s1)
298 80.23 1.74 1.15 30.27 3.57 3.14 44.15 2.77 2.34
303 64.57 2.66 1.73 27.58 5.00 4.41 37.49 4.21 3.85
308 52.44 4.20 2.54 24.89 6.86 5.99 32.09 5.85 5.08
313 44.5 5.74 3.54 23.16 9.16 7.85 29.43 7.91 6.88
318 38.05 7.74 4.88 21.08 12.06 10.28 26.06 10.11 9.06
323 33.20 9.45 6.34 19.85 16.54 14.10 24.08 13.44 11.64
Table 2
Diffusional activation energies of the THEDES components.
Activation energy (kJ mol1)
Menthol API
Menthol:Ibu (3:1) 53.5 54.9
Menthol:BA (3:1) 50.3 49.7
Menthol:PA (3:1) 48.5 47.5
Fig. 6. Plot of the diffusion coefficients vs Tg1.
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the other carboxylic acids. This can suggest that Ibu is in a dimeric
form.
Having determined the viscosity of the systems, it is possible to
evaluate if the diffusion mechanism observed for the THEDES stud-
ied obeys the Stokes-Einstein equation (Eq. (5))
D ¼ kT
cpgrS
ð5Þ
where k is the Boltzmann constant, T the absolute temperature, c a
constant, rS the hydrodynamic (Stokes) radius.
If a linear correlation is obtained between the diffusion coeffi-
cients and the Tg1, the diffusion mechanism obeys the Stokes-
Einstein equation. In our systems we observe, however, a clear
deviation from linearity (Fig. 6), which suggests that the diffusion
mechanism cannot be explained by the classical theory. This devi-
ation in the self-diffusion in THEDES has already been observed
and reported for NADES derived from choline chloride and it has
been proposed that the diffusion mechanism in the NADES must
be similar to the mechanism in ionic liquids, in which a species
migrates via jumping between voids or holes in the liquid created
by punctual thermal fluctuations [27,28]. The studied THEDES
although having a molecular component behave like an ionic liquidwith strong ionic/electrostatic interactions, in which the classical
diffusion theory does not apply.3.2. Solubility studies
The complexation of APIs with another component in the form
of a THEDES resulted in changes in the dissolution rate of the API,
as described in our previous work [16]. However it has not been
discussed the solubility of the API in the isotonic solution. Table 3
presents the solubility of the different APIs studied in this work
together with the solubility of the API when in the liquid THEDES
form.
Table 3
Solubility of APIs in powder form or complexed in THEDES in PBS
solution pH 7.4.
Solubility (mg/mL)
Ibu 2.1 ± 0.23
Menthol:ibu (3:1) 26.8 ± 2.62
BA 105.0 ± 11.85
Menthol:BA (3:1) 218.7 ± 21.71
PA 18.4 ± 2.13
Menthol:PA (2:1) 22.5 ± 2.38
Menthol:PA (3:1) 16.1 ± 1.90
Table 4
Time necessary for 50% of the API to diffuse through the
membrane.
Time (h)
Ibu >8
Menthol:ibu (3:1) 3
BA 3.5
Menthol:BA (3:1) 0.5
PA 2
Menthol:PA (2:1) 2
Menthol:PA (3:1) 3a
a The final concentration of the API in the receptor vessel is
lower that the pure API.
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behavior. The most evident increase in solubility is observed for
Ibu, which presents a 12 fold increase in the solubility from
2.1 mg/mL to 26.8 mg/mL. In the case of the system composed of
BA the solubility of the API increases 2 fold. However, for the sys-
tems containing PA the solubility only shows a slight increase
when in the form menthol:PA 2:1. Furthermore, the system men-
thol:PA 3:1 does not present any significant differences when com-
pared with the pure API. The formation of the ester in these
THEDES may result in a change in polarity and even in the inter-
molecular interactions explaining the behavior observed.
3.3. Permeability studies
Permeability and diffusion of the APIs in aqueous systems may
be changed when the compounds are combined in THEDES. Ng and
co-workers presented a systematic study of transmembrane diffu-0 1 2 3 4 5 6 7 8 9 10
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Fig. 7. Diffusion curves of the APIs and THEDES systemssion of Ibu through a series of different synthetic polymers and
have found that considerable differences may be observed depend-
ing on the properties of the membrane itself [29,30]. In this work,
we have studied the permeability using a commercially available
polyethersulfone membrane. The diffusion kinetics of the each
API and THEDES system are presented in Fig. 7.
Different diffusion profiles were obtained for the systems stud-
ied. While the diffusion is much higher in the case of the THEDES
systems containing Ibu and BA, the diffusion of PA is only slightly
enhanced when the API is in the THEDES form. For Menthol:PA
(3:1), the equilibrium is reached at a lower concentration that for
the pure API. As observed before menthol reacts with PA forming
an ester. Although the mixture remains liquid at room temperature
and continuous to behave as a THEDES, the formation of this new0 1 2 3 4 5 6 7 8 9 10
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through a PES membrane in PBS solution (pH 7.4).
Table 5
Permeability and diffusion coefficient calculated for the different systems.
Permeability
(105 cm s1)
Diffusion coefficient
(106 cm2 s1)
Ibu 4.6 ± 0.14 2.39 ± 0.43
Menthol:ibu (3:1) 14 ± 1.53 4.32 ± 0.34
BA 0.9 ± 0.01 0.73 ± 0.09
Menthol:BA (3:1) 6.8 ± 0.63 6.43 ± 1.42
PA 16 ± 2.3 3.14 ± 0.18
Menthol:PA (2:1) 18 ± 0.38 5.73 ± 0.43
Menthol:PA (3:1) 13 ± 0.59 4.66 ± 0.13
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curves.
As a comparative measure we estimated the time for 50% of the
drug to be diffused through the membrane, and the results are pre-
sented in Table 4.
In the case of Ibu and BA the changes in the diffusion through
the membrane, when the system is in the THEDES form are highly
noticeable. The system menthol:PA also does not present any
major differences when compared to the powder API. The differ-
ences are also highlighted in Table 5 which present the permeabil-
ity and diffusion coefficients calculated according to Eqs. (2) and
(3), respectively.
The permeability of the APIs and THEDES systems was calcu-
lated to be in the order of 105 cm/s, however significant differ-
ences may be observed between each pair API-THEDES. For
example in the case of Ibu there is a 3 fold increase in permeability,
whereas in the case of BA the increase is of 7.5 times. On the con-
trary, for the system with PA no significant differences were
observed.
The diffusion coefficient is a parameter which relates the
amount of API diffused with time. Hence, to a higher diffusion coef-
ficient corresponds a faster diffusion of the API through a mem-
brane. For all the systems studied an increase in the diffusion
coefficient of the API when complexed in the THEDES form is
observed (Table 5).
Taking into account the solubility results obtained it was
expected that the diffusion of the API in the THEDES form would
be faster than of the pure API, as the higher the solubility, the
higher the driving force. For the case of Ibu and BA the high
increase in solubility resulted in a high increase in the diffusion
as well. Once again, in the case of the system menthol:PA differ-
ences in the diffusion coefficient and permeability are not as signif-
icant as for the other two APIs.0.1
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Fig. 8. Solubility versus permeability of both APIs (open symbols) and THED3.4. Biopharmaceutics classification system
The experimental data obtained in this study can be fit in the
biopharmaceutics classification system plot of solubility, measured
as the volume required to dissolve 1 mg of API, versus permeability
(Fig. 8).
According to the values described in the literature for the limits
of the classification system, a drug is considered to be highly sol-
uble when the volume required to dissolve 1 mg is lower than
250 mL. In which concerns the permeability, a highly permeable
drug is one that has a permeability higher than 6  106 cm/s.
These were the values considered for the origin of Fig. 7. The differ-
ent classes of drugs are also defined in each quadrant. The systems
prepared present different behaviours, nonetheless overall an
increase in both solubility and permeability is noticed when the
API is in the THEDES form. Ibu, which in its native form falls in
Class II type of drugs, has when in combination with menthol
improved the solubility and permeability such that it can now be
classified as a Class I type. BA, classified as Class III drug improves
to a Class I system when in combination with menthol in a molar
ratio of 3:1. PA, is per se a highly soluble and permeable drug and
does not change its classification when in the THEDES form, on the
contrary, as it is esterified, the THEDES system presents a low
stability.4. Conclusions
The THEDES system prepared, namely menthol:ibu (3:1); men-
thol:BA (3:1), menthol:PA (2:1) and menthol:PA (3:1) were charac-
terized by NMR spectroscopy. The slope of the chemical shift of the
hydrogen bonded protons with temperature, which reflects the
activation energy of the hydrogen bond, correlated for all the
THEDES in this work with an intermolecular hydrogen bond, with
similar activation energies.
The transport properties of the mixture components in the
THEDES were also investigated by PFG NMR spectroscopy, which
showed to be independent of the molecular size of the carboxylic
acid (API). The diffusion coefficient of the APIs were lower than
of the menthol. A probable explanation is that the API forms
dimers, which decreases their mobility in the global THEDES sys-
tem. By combing the NMR diffusion and viscosity data, the diffu-
sion mechanism shows a deviation from the classical theory,
similar to the one observed in ionic liquids.
Regarding THEDES solubility and permeability behavior, it was
demonstrated that the THEDES systems prepared present not only
enhanced drug solubility in isotonic solution at pH 7.4, but also10000 100000
bility
Ibuprofen
Menthol:ibu (3:1)
Phenylacetic acid
Menthol:PA (2:1)
Benzoic acid
Menthol:BA (3:1)
Class IV
Class II
ES (closed symbols). Solubility in mg/mL and permeability in cm s1.
304 A.R.C. Duarte et al. / European Journal of Pharmaceutics and Biopharmaceutics 114 (2017) 296–304present enhanced permeability. The manipulation of the physical
state of the APIs, changing from solid form to liquid in the complex
THEDES system has proven to be a simple and efficient methodol-
ogy to improve the bioavailability of the APIs. In terms of biophar-
maceutical classification this is translated into a change from class
IV and III to class I systems, i.e. systems with high solubility and
permeability. The experimental data obtained and presented in
this work highlights the interest in deep eutectic systems as new
formulations for improved therapeutics and the results presented
open new perspectives in pharmaceutical engineering.
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